Castle Biosciences Inc (CSTL)
27.86
-0.14
(-0.50%)
USD |
NASDAQ |
Sep 27, 16:00
27.85
-0.01
(-0.04%)
After-Hours: 20:00
Castle Biosciences SG&A Expense (Annual): 180.15M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 180.15M |
| December 31, 2022 | 143.00M |
| December 31, 2021 | 86.74M |
| December 31, 2020 | 48.13M |
| Date | Value |
|---|---|
| December 31, 2019 | 29.84M |
| December 31, 2018 | 16.47M |
| December 31, 2017 | 15.26M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
29.84M
Minimum
2019
180.15M
Maximum
2023
97.57M
Average
86.74M
Median
2021
SG&A Expense (Annual) Benchmarks
| Danaher Corp | 7.252B |
| Exact Sciences Corp | 1.620B |
| Illumina Inc | 1.612B |
| Mettler-Toledo International Inc | 904.11M |
| Natera Inc | 618.31M |